Werbung
Werbung

AVXL

AVXL logo

Anavex Life Sciences

4.28
USD
Gesponsert
+0.01
+0.12%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

4.29

+0.02
+0.47%

AVXL Ergebnisberichte

Positives Überraschungsverhältnis

AVXL übertreffen die 24 der letzten 36Schätzungen.

67%

Nächster Bericht

Datum des nächsten Berichts
05. Feb. 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.11
Implizierte Änderung von Q4 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q1 25 (Revenue/ EPS)
--
/
-21.43%

Anavex Life Sciences earnings per share and revenue

On 25. Nov. 2025, AVXL reported earnings of -0.11 USD per share (EPS) for Q4 25, beating the estimate of -0.15 USD, resulting in a 28.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q4 2025, Anavex Life Sciences reported EPS of -$0.11, beating estimates by 28.1%, and revenue of $0.00, 0% as expectations.
The stock price moved up 11.56%, changed from $3.46 before the earnings release to $3.86 the day after.
The next earning report is scheduled for 05. Feb. 2026.
Based on 5 analysts, Anavex Life Sciences is expected to report EPS of -$0.11 and revenue of -- for Q1 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung